AGO2 and cardiac hypertrophy: Qian et al. (87) showed that IGF2BP2 recognized m6A modification in miR-133a target sequence, and then formed a complex with argonaute 2 (AGO2) to facilitate miR-133a’s accumulation on target mRNAs, thereby preventing cardiac hypertrophy.